Most cited article - PubMed ID 38446233
A-series agent A-234: initial in vitro and in vivo characterization
The risk of the use of toxic chemicals for unlawful acts has been a matter of concern for different governments and multilateral agencies. The Organisation for the Prohibition of Chemical Weapons (OPCW), which oversees the implementation of the Chemical Weapons Convention (CWC), considering recent events employing chemical warfare agents as means of assassination, has recently included in the CWC "Annex on Chemicals" some organophosphorus compounds that are regarded as acting in a similar fashion to the classical G- and V-series of nerve agents, inhibiting the pivotal enzyme acetylcholinesterase. Therefore, knowledge of the activity of the pyridinium oximes, the sole class of clinically available acetylcholinesterase reactivators to date, is plainly justified. In this paper, continuing our research efforts in medicinal chemistry on this class of toxic chemicals, we synthesized an A-230 nerve agent surrogate and applied a modified Ellman's assay to evaluate its ability to inhibit our enzymatic model, acetylcholinesterase from Electrophorus eel, and if the clinically available antidotes are able to rescue the enzyme activity for the purpose of relating the findings to the previously disclosed in silico data for the authentic nerve agent and other studies with similar A-series surrogates. Our experimental data indicates that pralidoxime is the most efficient compound for reactivating acetylcholinesterase inhibited by A-230 surrogate, which is the opposite of the in silico data previously disclosed.
- Keywords
- A-230, Acetylcholinesterase, Antidotes, Chemical Weapons Convention, Nerve agent surrogates,
- MeSH
- Acetylcholinesterase * metabolism MeSH
- Antidotes pharmacology MeSH
- Chemical Warfare Agents * toxicity MeSH
- Cholinesterase Inhibitors * toxicity MeSH
- Nerve Agents * toxicity MeSH
- Organothiophosphorus Compounds toxicity MeSH
- Oximes * pharmacology MeSH
- Pralidoxime Compounds pharmacology MeSH
- Pyridinium Compounds * pharmacology MeSH
- Cholinesterase Reactivators * pharmacology MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Acetylcholinesterase * MeSH
- Antidotes MeSH
- Chemical Warfare Agents * MeSH
- Cholinesterase Inhibitors * MeSH
- Nerve Agents * MeSH
- Organothiophosphorus Compounds MeSH
- Oximes * MeSH
- pralidoxime MeSH Browser
- Pralidoxime Compounds MeSH
- Pyridinium Compounds * MeSH
- Cholinesterase Reactivators * MeSH
This phytochemical study presents the isolation of eight alkaloids from Zephyranthes citrina Baker. The structures of the new alkaloids, zephycitrine (1) and 6-oxonarcissidine (2), were established by analysis of spectroscopic and spectrometric data. Processing the EtOH extract under acid-base conditions yielded the unreported isolation artifacts 3 and 4. This work also provides analytical data for alkaloids not properly described in the literature (5 and 6). The hippeastidine/zephyranine scaffolds in derivatives 3, 4, and 8-10 are also thoroughly discussed. Furthermore, a cytotoxicity screening of 25 Amaryllidaceae alkaloids isolated from Z. citrina was performed. Only the known alkaloids haemanthamine (12), haemanthidine (13), and lycorine (27) showed significant cell growth inhibition.
- MeSH
- Amaryllidaceae Alkaloids * pharmacology chemistry isolation & purification MeSH
- Amaryllidaceae * chemistry MeSH
- Phenanthridines pharmacology chemistry MeSH
- Antineoplastic Agents, Phytogenic pharmacology chemistry isolation & purification MeSH
- Humans MeSH
- Molecular Structure MeSH
- Drug Screening Assays, Antitumor MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Amaryllidaceae Alkaloids * MeSH
- Phenanthridines MeSH
- Antineoplastic Agents, Phytogenic MeSH
- hemanthamine MeSH Browser
- lycorine MeSH Browser